ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

ngµç×ÓÓÎÏ·ÍŶÓÔÚÉñ¾­²¡ÀíÐÔÌÛÍ´µÄ±í¹Ûµ÷¿Ø»úÖÆÑо¿ÖÐÈ¡µÃÐÂÏ£Íû

¸å¼þȪԴ£º£ºÖÐɽҽѧԺ ±à¼­£º£ºÌ¸Ï£¡¢Íõ¶¬Ã· ÉóºË£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÐÅÎľý£©Éñ¾­²¡ÀíÐÔÌÛÍ´Ó°ÏìÁËÈ«ÇòÔ¼7-10%µÄÉú³Ý£¬£¬¶ÔÈËÃǵÄÉúÑÄÖÊÁ¿Ôì³ÉÖØ´óÓ°Ï죬£¬²¢ÑÏÖØ·Áº¦¾«ÉñÐÄÀí¿µ½¡¡£ÓÉÓÚͨÀýÕòÍ´Ò©ÍùÍùÔÚÌṩÓÐÏÞµÄÖÎÁÆÐ§¹ûµÄͬʱÒýÆðÑÏÖØµÄ¶¾¸±×÷Ó㬣¬Éñ¾­ÐÔÌÛÍ´µÄÁÙ´²ÖÎÀíÒ»Ö±ÃæÁÙÖØ´óÌôÕ½¡£ÎªÁË¿ª·¢ÐµÄÖÎÁÆÕ½ÂÔ£¬£¬Ïàʶ¼²²¡µÄ»ù±¾²¡ÀíÐÄÀí»úÖÆÖÁ¹ØÖ÷Òª¡£

¶àÌõÀíµÄ±í¹Ûµ÷¿ØÐÞÊΣ¨°üÀ¨DNA¡¢RNAºÍÂѰ×ÖÊ£©Êǵ÷ÀíÍ´Ïà¹Ø»ùÒò±í´ïµÄÖ÷Òª»úÖÆ¡£¼ÈÍùµÄÑо¿Ö÷Òª¼¯ÖÐÔÚÑо¿DNA¼×»ù»¯ºÍ×éÂѰ×ÐÞÊÎÉÏ¡£Ô½À´Ô½¶àµÄÖ¤¾ÝÅú×¢£¬£¬mRNAˮƽµÄÐÞÊÎÒ²¿ÉÒÔÔÚµ÷Àí»ùÒò±í´ï·½ÃæÊ©Õ¹ºã¾Ã×÷Óá£N4-ÒÒõ£°ûà×à¤(ac4C)ÊÇÒ»ÖÖ¹ÅÀÏÇÒ½ø»¯ÉÏÊØ¾ÉµÄÐÞÊΣ¬£¬±£´æÓÚ´Ó¹Åϸ¾úµ½ÈËÀàµÄÆÕ±éRNAÖС£Ð½üÑо¿·¢Ã÷ac4CÄܹ»Í¨¹ýת¼ºó»úÖÆµ÷ÀímRNA·­ÒëЧÂʺÍÎȹÌÐÔ£¬£¬µ«ÆäÔÚÉñ¾­ÐÔÌÛÍ´±¬·¢¿ªÕ¹ÖÐÆðµ½µÄ×÷Óû¹ÉÐδ¿ÉÖª¡£

2023Äê10ÔÂ25ÈÕ£¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÐÅÎľý½ÌÊÚ£¬£¬ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄл¾´¶Ø½ÌÊÚ¡¢Ð»µ¤½ÌÊÚÏàÖú£¬£¬ÔÚAdvanced ScienceÆÚ¿¯ÉϽÒÏþÁËÌâΪ¡°Ac4C Enhances the Translation Efficiency of Vegfa mRNA and Mediates Central Sensitization in Spinal Dorsal Horn in Neuropathic Pain¡±µÄÑо¿ÂÛÎÄ¡£

ÍŶÓÑо¿Ð§¹û֤ʵÁËmRNAµÄac4CÐÞÊμÓ×ÅÃÔ¾­ËðÉËÓÕµ¼µÄ´óÊóÉñ¾­²¡ÀíÐÔÌÛÍ´Àú³Ì¡£Ñо¿Õßͨ¹ýÉúÎïÐÅϢѧÆÊÎöºÍacRIPÑéÖ¤£¬£¬È·¶¨ÁËVegfa mRNA 3¡¯UTRµÄÌØ¶¨Î»µãÔÚÌÛÍ´Ä£×ÓÖÐÌåÏÖ³öac4CÐÞÊÎˮƽµÄÏÔÖøÔöÌí¡£Í¨¹ýÕûºÏ¶à¸öOmicsÊý¾Ý¼¯£¨°üÀ¨acRIP-seq¡¢Ribo-seqºÍRNA-seq£©£¬£¬·¢Ã÷Vegfa mRNAÉϵÄac4CÐÞÊοÉÄÜͨ¹ýÓ°Ïì·­ÒëЧÂÊÀ´µ÷ÀíÏÂÓÎVEGFAÂѰױí´ï¡£½øÒ»²½µÄÔÚÌåºÍÀëÌåʵÑé֤ʵac4CÐÞÊε÷¿Ø·­ÒëЧÂʽ鵼µÄVEGFAÉϵ÷ÔöÇ¿Á˼¹ËèÖÐÊàÃô»¯£¬£¬²¢Ëæºóµ¼Ö»úеÐÔÍ´¾õÃô¸ÐºÍÈÈÍ´¾õÃô¸Ð¡£ÕâЩЧ¹ûΪac4CÐÞÊμÓÈëµ÷Àí°Ð·Ö×Ó·­ÒëЧÂʼ°ÆäÔÚÉñ¾­ÐÔÌÛÍ´ÖеÄ×÷ÓÃÌṩÁËÖ±½ÓÖ¤¾Ý¡£

989C01CAC3CF93AFCD9D42468C8_B77F51A9_12E1A

¿ÆÑ§¼Ù˵ģʽͼ£º£ºac4CÐÞÊÎøNAT10½éµ¼µÄVEGFA±í´ïÉϵ÷¼Ó×ÅÃÔ¾­²¡ÀíÐÔÌÛÍ´µÄ»úÖÆ

ngµç×ÓÓÎÏ·ÖÐɽҽѧԺ¸±½ÌÊÚÐìæÃ¡¢²©Ê¿Ñо¿ÉúÍõ¾²ºÍngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½ÔºÚùÑÞΪ¸ÃÂÛÎĵÄÅäºÏµÚÒ»×÷Õß¡£¸ÃÑо¿Êܹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿¡¢¹ã¶«Ê¡×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿ºÍ¹ãÖÝÊпƼ¼ÍýÏëµÈÏîÄ¿×ÊÖú¡£

ÂÛÎÄÁ´½Ó£º£ºhttps://onlinelibrary.wiley.com/doi/10.1002/advs.202303113

¡¾ÍøÕ¾µØÍ¼¡¿